Professional overview
Li Jingjing is an Associate Chief Physician and Master's Supervisor in the Department of Medical Oncology at Sun Yat-sen University Cancer Center, specializing in medical treatment of melanoma, soft tissue sarcoma, and gastrointestinal tumors, as well as immunotherapy for solid tumors.
SpecialtyMedical oncology
Clinical titleAssociate Chief Physician
Academic rolesMaster's Supervisor
DepartmentDepartment of Medical Oncology
HospitalSun Yat-sen University Cancer Center
CityGuangzhou
Areas of focus
MelanomaFocuses on medical treatment of melanoma
Soft tissue sarcomaFocuses on medical treatment of soft tissue sarcoma
Gastrointestinal tumorsFocuses on medical treatment of gastrointestinal tumors
Immunotherapy for solid tumorsFocuses on immunotherapy for solid tumors
Experience & recognition
- PhD in Immunology from the University of Newcastle, Australia
- Principal investigator of 4 research grants, including a National Natural Science Foundation of China (NSFC) grant
- First or corresponding author of over 10 high-impact publications, including in JACI, Journal of Immunology, and Clinical and Translational Medicine
- Research presented at ASCO, ESMO, and the Society for Melanoma Research (SMR) Annual Meeting
- 1 patent application filed
Frequently asked questions
What does Dr. Li Jingjing specialize in?
Medical treatment of melanoma, soft tissue sarcoma, and gastrointestinal tumors, and immunotherapy for solid tumors
Which hospital and department is Dr. Li Jingjing in?
Department of Medical Oncology at Sun Yat-sen University Cancer Center
Sources
- Compiled from public information about the doctor's clinical title, department and areas of focus, rewritten by Find China Doctors.
- Medical licence: National Health Commission doctor registry
Dr. Li Jingjing has not reviewed this page.
